(4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one Suppliers list
|
|
| (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one Basic information |
Product Name: | (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one | Synonyms: | (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one;2H-Indeno[5,4-f]quinolin-2-one, 7-[(1R)-1,5-dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-, (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)- | CAS: | 158493-17-5 | MF: | C28H49NO | MW: | 415.69 | EINECS: | | Product Categories: | | Mol File: | 158493-17-5.mol | |
| (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one Chemical Properties |
Boiling point | 505.2±19.0 °C(Predicted) | density | 0.951±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | Soluble in DMSO | pka | -0.48±0.70(Predicted) |
| (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one Usage And Synthesis |
Uses | MK 386 acts as a selective human type 1 5α-reductase inhibitor which may be used in the treatment of male pattern baldness. Also may be used to instigate androgen deprivation in the treatment of disseminated prostate cancer. | storage | Store at -20°C |
| (4aR,4bS,6aR,7R,9aS,9bS,10S,11aR)-7-[(1R)-1,5-Dimethylhexyl]hexadecahydro-1,4a,6a,10-tetramethyl-2H-indeno[5,4-f]quinolin-2-one Preparation Products And Raw materials |
|